Promoting Cervical Cancer Screening for Emergency Department Patients

Cervical Cancer Clinical Trial

Official title:

Piloting Interventions to Improve Adherence to Cervical Cancer Screening Recommendations Among Emergency Department Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03483610
• Other study ID #: RSRB00070962
• Status: Completed
• Phase: N/A
• Start date: June 25, 2018
• Est. completion date: May 31, 2019

Study information

• Verified date: August 2019
• Source: University of Rochester
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to learn methods to encourage women to get recommended cervical cancer screening. Cervical cancer screening is an important part of cervical cancer prevention. The study team will determine if the patient is currently up-to-date with cervical cancer screening recommendations. If the patient is not up-to-date, then they will be randomly assigned to one of two interventions. One intervention consists only of referral to a women's health care provider to obtain cervical cancer screening. The other intervention consists of receiving a total of 3 text messages at 30-day intervals encouraging follow-up for cervical cancer screening.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 450
• Est. completion date: May 31, 2019
• Est. primary completion date: May 31, 2019
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 21 Years to 65 Years

Eligibility

Inclusion Criteria:

• Registered patient in the Emergency Department of the University of Rochester Medical Center

• Women

• Age 21 - 65

Exclusion Criteria:

• Past hysterectomy with cervical removal

• Known infection with HIV (screening recommendations for women with HIV differ from the general population)

• Non-English speaking

• Inability to consent

• Lack of text-capable mobile phone and/or inability to use text function

Related Conditions & MeSH terms

• Cervical Cancer
• Emergencies
• Uterine Cervical Neoplasms

Intervention

Behavioral:
• Provider Referral
Participants will be asked if they are up-to-date on their cervical cancer screening. If not they will be referred to a provider. At the end of the study they will receive a 10 minute follow up telephone survey to collect data screening status and views on cervical cancer screening.
• Text Messaging
Participants will be asked if they are up-to-date on their cervical cancer screening. If not they will be referred to a provider. They will also receive a total of 3 text messages at 30-day intervals encouraging follow-up for cervical cancer screening. They will receive a 10 minute follow up telephone survey to collect data screening status and views on cervical cancer screening.

Locations

Country	Name	City	State
United States	University of Rochester, Department of Emergency Medicine	Rochester	New York

Sponsors (2)

Lead Sponsor	Collaborator
University of Rochester	National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	number of participants who scheduled or completed cervical cancer screening		150 days